This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Kearns AC , Robinson JA , Shekarabi M , Liu F , Qin X , Burdo TH
Caspase-1-associated immune activation in an accelerated SIV-infected rhesus macaque model
J Neurovirol. 2018 Aug;24(4) :420-431
PMID: 29611111 PMCID: PMC6526524 URL: https://www.ncbi.nlm.nih.gov/pubmed/29611111
AbstractIn the antiretroviral therapy (ART) era, chronic HIV infection is primarily associated with chronic inflammation driving comorbidities such as cardiovascular disease and neurocognitive impairment. Caspase-1 activation in leukocytes has been documented in HIV infection; however, whether caspase-1 activation and the downstream pro-inflammatory cytokines interleukin-1beta (IL-1beta) and interleukin-18 (IL-18) contribute to chronic inflammation in HIV comorbidities remains undetermined. The relationship between the caspase-1 cascade and persistent inflammation in HIV has not been investigated. Here, we used an accelerated simian immunodeficiency virus (SIV)-infected rhesus macaque model with or without ART to investigate the dynamics of caspase-1 and immune cell activation before infection, 21 days post infection (dpi), and necropsy. Caspase-1, IL-18, IL-1beta, and immune markers were measured both in the circulation and lymphoid tissues. We found a significant increase in caspase-1 and IL-18 in SIV infection that positively correlated with inflammatory monocytes and negatively correlated with CD4(+) T cell counts. ART attenuated these effects at necropsy in the circulation. Further, lymph nodes from SIV+ or SIV+ART animals had increased activation of caspase-1 and potential upstream priming of the NF-kappaB pathway, indicating that tissue-specific immune activation persists with ART. Together, these results shed light on the interconnectedness of the caspase-1 pathway and peripheral immune activation and further indicate that ART is not sufficient for suppressing inflammation. The caspase-1 pathway may provide novel therapeutic targets to improve HIV-associated comorbidities and health outcomes in the context of viral suppression.
Notes1538-2443 Kearns, Alison C Robinson, Jake A Shekarabi, Masoud Liu, Fengming Qin, Xuebin Burdo, Tricia H NS082116/National Institute of Neurological Disorders and Stroke CA166144/National Cancer Institute HL130233/National Heart, Lung, and Blood Institute AA024984/National Institute on Alcohol Abuse and Alcoholism Journal Article United States J Neurovirol. 2018 Apr 2. pii: 10.1007/s13365-018-0630-8. doi: 10.1007/s13365-018-0630-8.